Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exatecan mesylate in metastatic gastric cancer
NCT00017212Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2001
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of exatecan in gastric cancer (GC), sponsored by Daiichi Sankyo Co., Ltd.. Started Apr 2001; status: completed.
02
Drugs
exatecan
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00017212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017212.